Hypermethylation of the p16(INK4a) promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis

Cancer Research

Volumn 58, Issue 17, 1998, Pages 3942-3945

  Hsieh, Chih Jen ^a   Klump, Bodo ^a   Holzmann, Karlheinz ^a   Borchard, Franz ^b   Gregor, Michael ^a   Porschen, Rainer ^a,c  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; DNA METHYLATION; GENE REPRESSION; HUMAN; HUMAN TISSUE; MALIGNANT TRANSFORMATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; TUMOR SUPPRESSOR GENE; ULCERATIVE COLITIS; COLON RESECTION; GENETICS; PROGNOSIS;

PROTEIN P16INK4A;

COLECTOMY; COLITIS, ULCERATIVE; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; HUMANS; PROGNOSIS; PROMOTER REGIONS (GENETICS);

EID: 0032148387     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Serrano, M., Hannon, G. J., and Beach, D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK 4. Nature (Lond.), 366: 704-707, 1993.
2. Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., and Skolnick, M. H. A cell cycle regulator potentially involved in genesis of many tumor types. Science (Washington DC), 246: 436-440, 1994.
3. Sherr, C. J. Cancer cell cycles. Science (Washington DC), 274: 1672-1677, 1996.
4. Barrett, M. T., Galipeau, P. C, Sanchez, C. A., Emond, M. J., and Reid, B. J. Determination of the frequency of loss of heterozygosity in esophageal adenocarcinoma by cell sorting, whole genome amplification and microsatellite polymorphisms. Oncogene, 12: 1873-1878, 1996.
5. Gonzalez-Zulueta, M., Bender, C. M., Yang, A. S., Nguyen, T., Beart, R. W., Van Tornout, J. M., and Jones, P. A. Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res., 55: 4531-4535, 1995.
6. Spruch, C. H., Gonzalez-Zulueta, M., Shibata, A., Simoneau, A. R., Lin, M-F., Gonzales, F., Tsai, Y., and Jones, P. A. p16 gene in uncultured tumors. Nature (Lond.), 370: 183-184, 1994.
7. Cairns, P., Polascik, T. J., Eby, Y., Tokino, K., Califano, J., Merlo, A., Mao, L., Herath, J., Jenkins, R., Westra, W., Rutter, J., Buckler, A., Gabrielson, E., Tockman, M., Cho, K. R., Hedrick, L., Bova, G. S., Isaacs, W., Koch, W., Schwab, D., and Sidransky, D. Frequency of homozygous deletion at p16/CDKN2 in primary human tumors. Nat. Genet., 11: 210-212, 1995.
8. Li, E., Beard, C., and Jaenisch, R. Role for DNA methylation in genomic imprinting. Nature (Lond.), 366: 362-365, 1993.
9. Costello, J. F., Berger, M. S., Huang, H-J. S., and Cavenee W. K. Silencing of p16/CDKN2 expression in human gliomas by methylation and chromatin condensation. Cancer Res., 56: 2405-2410, 1996.
10. INK4A characterize the major types of hematological malignancies. Cancer Res., 57: 837-841, 1997.
11. INK4a promoter is hypermethylated at a high frequency in esophageal adenocarcinoma. Cancer Res., 57: 2619-2622, 1997.
12. Ahuja, N., Mohan, A. L., Li. Q., Stolker J. M., Herman J. G., Hamilton, S. R., Baylin, S. B., and Issa, J-P. J. Association between CpG island methylation and microsatellite instability in colorectal cancer. Cancer Res., 57: 3370-3374, 1997.
13. Schutte, M., Hruban, R. H., Geradts, J., Maynard, R., Hilgers, W., Rabindran, S. K., Moskaluk C. A., Hahn, S. A., Schwarte-Waldhoff, I., Schmiegel, W., Baylin, S. B., Kern, S. E., and Herman, J. G. Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas. Cancer Res., 57: 3126-3130, 1997.
14. Herman, J. G., Merlo, A., Mao, L., Lapidus, R. G., Issa, J. P., Davidson, N. E., Sidransky, D., and Baylin, S. B. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res., 55: 4525-4530, 1995.
15. Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B., and Sidransky, D. 5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med., 1: 686-692, 1995.
16. Ekbom, A. Cancer in inflammatory bowel disease. Curr. Opin. Gastroen., 11: 316-320, 1995.
17. Riddell, R. H., Goldman, H., Ransohoff, D. F., Appelman, H. D., Fenoglio, C. M., Haggitt, R. C., Ahren, C., Correa, P., Hamilton, S. R., and Morson, B. C. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum. Palhol., 14: 931-966, 1983.
18. Forschen, R., Robin, U., Schumacher, A., Schauseil, S., Borchard, F., Hengels, K. J., and Strohmeyer, G. DNA aneuploidy in Crohn's disease and ulcerative colitis: results of a comparative flow cytometric study. Gut, 33: 663-667, 1992.
19. Vindelov, L. L., Christensen, I. J. and Nissen, N. I. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry, 3: 323-327, 1983.
20. Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., and Baylin, S. B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc, Natl. Acad. Sci. USA, 93: 9821-9826, 1996.
21. Barren, M. T., Sanchez, C. A., Galipeau, P. C, Neshat, K., Emond, M., and Reid, B. J. Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus. Oncogene, 13: 1867-1873, 1996.
22. Hu, Y. X., Watanabe, H., Ohtsubo, K., Yamaguchi, Y., Ha, A., Okai, T., and Sawabu, N. Frequent loss of p16 expression and its correlation with clinicopathological parameters in pancreatic carcinoma. Clin. Cancer Res., 3: 1473-1477, 1997.
23. Waf1 genes are associated with aggressive variants of mantle cell lymphomas. Blood, 89: 272-280, 1997.
24. Reed, J. A., Loganzo, F., Shea, C. R., Walker, G. J., Flores, J. F., Glendening, J. M., Bogdany, J. K., Shiel, M. J., Haluska, F. G., Fountain, J. W., and Albino, A. P. Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression. Cancer Res., 55: 2713-2718, 1995.
25. Rubin, C. E., Haggitt, R. C., Burmer, G. C., Brentnall, T. A., Stevens, A. C., Levine, D. S., Dean, P. J., Kimmey, M., Perera, D., and Rabinovitch, P. DNA aneuploidy in colonie biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology, 103: 1611-1620, 1992.